Citadel Advisors’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $674K | Buy |
100,357
+83,904
| +510% | +$564K | ﹤0.01% | 3719 |
|
|
2025
Q1 | $149K | Sell |
16,453
-54,216
| -77% | -$490K | ﹤0.01% | 4999 |
|
|
2024
Q4 | $1.22M | Sell |
70,669
-17,555
| -20% | -$304K | ﹤0.01% | 3082 |
|
|
2024
Q3 | $1.41M | Sell |
88,224
-42,225
| -32% | -$675K | ﹤0.01% | 2798 |
|
|
2024
Q2 | $1.86M | Buy |
130,449
+60,773
| +87% | +$866K | ﹤0.01% | 2508 |
|
|
2024
Q1 | $987K | Buy |
+69,676
| New | +$987K | ﹤0.01% | 3205 |
|
|
2022
Q3 | – | Sell |
-12,947
| Closed | -$158K | – | 6715 |
|
|
2022
Q2 | $158K | Sell |
12,947
-51,452
| -80% | -$628K | ﹤0.01% | 5102 |
|
|
2022
Q1 | $604K | Sell |
64,399
-44,395
| -41% | -$416K | ﹤0.01% | 4257 |
|
|
2021
Q4 | $1.86M | Buy |
+108,794
| New | +$1.86M | ﹤0.01% | 3142 |
|